Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

GM Helix Acqua Implant,Ti,3.75X16: medical device reports filed with FDA

601 reports name it, 2020–2026. Manufacturer given most often on reports: Jjgc. Product code DZE.

601
device reports naming the brand
0% of all MAUDE reports · about 100 a year
238
reports, 12 months to August 2026
154 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

601 medical device reports received by FDA name the brand "GM Helix Acqua Implant,Ti,3.75X16" (endosseous dental implant); the manufacturer given most often on reports is Jjgc; received from July 2020 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.

238 reports arrived in the 12 months to August 2026, up 55% from 154 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (79.4%), loss of osseointegration (12.5%) and difficult to insert (1.2%). The patient problems coded most often are pain, fibrosis and hemorrhage/blood loss/bleeding. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

01632Sep 2021: 2Oct 2021: 0Nov 2021: 5Dec 2021: 02022Jan 2022: 1Feb 2022: 0Mar 2022: 7Apr 2022: 5May 2022: 1Jun 2022: 2Jul 2022: 8Aug 2022: 6Sep 2022: 2Oct 2022: 3Nov 2022: 11Dec 2022: 22023Jan 2023: 4Feb 2023: 2Mar 2023: 5Apr 2023: 3May 2023: 5Jun 2023: 5Jul 2023: 3Aug 2023: 6Sep 2023: 1Oct 2023: 11Nov 2023: 7Dec 2023: 42024Jan 2024: 15Feb 2024: 7Mar 2024: 4Apr 2024: 12May 2024: 8Jun 2024: 6Jul 2024: 13Aug 2024: 11Sep 2024: 14Oct 2024: 15Nov 2024: 9Dec 2024: 72025Jan 2025: 17Feb 2025: 19Mar 2025: 13Apr 2025: 8May 2025: 0Jun 2025: 32Jul 2025: 10Aug 2025: 10Sep 2025: 8Oct 2025: 29Nov 2025: 21Dec 2025: 112026Jan 2026: 22Feb 2026: 14Mar 2026: 29Apr 2026: 18May 2026: 27Jun 2026: 20Jul 2026: 17Aug 2026: 22

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

0891782020: 620202021: 2320212022: 4820222023: 5620232024: 12120242025: 17820252026: 1692026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%601
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report91.3%549
Voluntary report0%0
User facility report0%0
Distributor report8.7%52
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate47779.4%62.8%
Loss of osseointegration7512.5%22.4%
Difficult to insertthe device was hard to insert71.2%0.4%
Fracturea broken bone30.5%1.6%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Painpain, site not specified14624.3%
Fibrosis13422.3%
Hemorrhage/blood loss/bleeding335.5%
Inflammationinflammation305%
Swelling/ edema284.7%
Fistula213.5%
Hyperresponsive to stimuli101.7%
Abscessa collection of pus30.5%
Hypersensitivity/allergic reaction20.3%
Sinus perforation20.3%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureGM Helix Acqua Implant,Ti,3.75X16Product code DZEAll MAUDE reports
Reports6013,924,24126,136,888
Share of that pool—0%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer91.3%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about GM Helix Acqua Implant,Ti,3.75X16 reports

How many FDA reports name GM Helix Acqua Implant,Ti,3.75X16?

601 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 238 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (79.4%), loss of osseointegration (12.5%), difficult to insert (1.2%) and fracture (0.5%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (91.3%) and distributor reports (8.7%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that GM Helix Acqua Implant,Ti,3.75X16 was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.